About Us
Our Story
Team
Technology
Clinical Development
Products
Our Clinical Trials
For Patients
Home
Media
Partnerships
Contact Us
linkedin
twitter
Tuning In: Intensity’s immune-based chemo delivery tech attracts backing of British billionaire Jim Mellon
November 2, 2018
Source: November 2, 2018 published on Endpoints.com
Back to Top
